CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 58 enrolled
Drug / intervention
Triamcinolone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01995045
NCT01995045Phase 4Completed
CompareCT.gov

The Effects of Triamcinolone Acetonide With Retrobulbar Anesthesia on Postoperative Pain Control Following Vitreoretinal Surgery

Emory University·interventional·Posted Nov 26, 2013·Updated Mar 21, 2017

In Brief

A Phase 4 clinical trial evaluating Triamcinolone and Bupivicaine Hydrochloride for Retinal Detachment and 2 related conditions. Completed, enrolled 58 participants across 1 site.

Detailed Summary

The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinal Detachment, Proliferative Vitreoretinopathy, Retinoschisis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 26, 2013
Enrollment StartJul 1, 2012
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.6 years ago

Interventions

Triamcinolonedrug

Retrobulbar anesthesia

Bupivicaine Hydrochloridedrug

Retrobulbar anesthesia